You are here

Clinical Trials: Digestive System Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, May 12, 2021 - 12:00
Condition:   Ulcerative Colitis
Interventions:   Drug: Prednisone;   Drug: Azathioprine;   Drug: Adalimumab;   Biological: umbilical cord blood mononuclear cells
Sponsor:   Shandong Qilu Stem Cells Engineering Co., Ltd.
Posted: Monday, April 19, 2021 - 12:00
Conditions:   Perianal Fistula;   Crohn's Disease
Interventions:   Procedure: Seton Placement;   Drug: AVB-114
Sponsors:   Avobis Bio, LLC;   Alimentiv Inc.
Not yet recruiting
Posted: Tuesday, March 30, 2021 - 12:00
Condition:   Acute-On-Chronic Liver Failure
Intervention:   Genetic: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
Sponsor:   Hai Li
Not yet recruiting
Posted: Wednesday, March 10, 2021 - 12:00
Condition:   Perianal Fistula Due to Crohn's Disease (Disorder)
Intervention:   Drug: Mesenchymal stem cells
Sponsor:   Amy Lightner
Not yet recruiting
Posted: Friday, February 19, 2021 - 12:00
Condition:   Fatty Liver, Nonalcoholic
Interventions:   Drug: Cilostazol 50 MG;   Drug: Placebo
Sponsor:   Sadat City University
Posted: Wednesday, February 17, 2021 - 12:00
Condition:   Patients Having a Scheduled Abdominal Surgery Procedure
Interventions:   Other: blood samples;   Other: biopsy of abdominal paroie
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Thursday, February 11, 2021 - 12:00
Condition:   Anal Fistula
Intervention:   Procedure: Adipose tissue injection associated with endorectal advancement flap.
Sponsor:   Hospital Plató
Posted: Wednesday, December 16, 2020 - 12:00
Condition:   Gastrointestinal Fistula
Intervention:   Procedure: injection of emulsified adipose tissue stromal vascular fraction
Sponsor:   Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Posted: Monday, September 14, 2020 - 12:00
Condition:   Crohn Colitis
Interventions:   Drug: remesetemcel-L;   Other: Placebo
Sponsors:   The Cleveland Clinic;   Mesoblast, Inc.
Not yet recruiting
Posted: Thursday, September 10, 2020 - 12:00
Condition:   Ulcerative Colitis
Interventions:   Drug: Remestemcel-L;   Other: Placebo
Sponsors:   The Cleveland Clinic;   Mesoblast, Inc.
Not yet recruiting